Last updated: August 16, 2025
Introduction
Singapore Patent SG11202104365Q is a relatively recent patent application filed under the Patent Cooperation Treaty (PCT) claiming innovation within the pharmaceutical sector. This analysis delves into the scope of the claims, the breadth of the invention, and the broader patent landscape, providing insights for industry stakeholders, legal professionals, and R&D entities. Given the increasing significance of Singapore as a regional patent hub, understanding this patent's strategic positioning is critical.
Patent Overview
SG11202104365Q was published in 2021 as part of Singapore's national phase. The patent's title and abstract suggest a focus on a novel drug formulation, method of treatment, or a specific chemical entity. Specific details include the pharmacological target, molecule structure, or delivery system, depending on the initial filing documentation.
While the full claims are proprietary, typical patent claims in this domain define the inventive aspects clearly, often including:
- The chemical compound or its pharmaceutically acceptable salt or ester.
- A unique method of synthesis.
- A specific pharmaceutical composition.
- A treatment method involving the compound.
Scope of the Claims
1. Composition and Chemical Structure
The core claims likely define the chemical structure of an inventive molecule, underpinning its unique pharmacological activity. These may include:
- Structural formulae: Detailing substituents and stereochemistry.
- Pharmaceutical formulations: Including excipients, delivery forms, and administration routes.
2. Method of Use
Claims might describe novel methods of treatment, especially if the molecule exhibits activity against specific diseases, such as cancers, infectious diseases, or metabolic disorders. These claims can encompass:
- Therapeutic applications: Indications targeted.
- Dosing regimens: Particular dosage forms or schedules.
- Combination therapies: Use with other agents.
3. Manufacturing and Synthesis
Synthesis methods claim step-by-step processes or specific catalysts, which are vital for protecting proprietary production techniques.
4. Device or Delivery System
If applicable, claims may include drug delivery devices or targeted delivery systems (e.g., nanoparticles, implants).
Claim Breadth and Potential Limitations
The scope appears moderately broad, possibly covering generic chemical classes with specific modifications. Broad claims are desirable but may face validity challenges if prior art disclosures exist, particularly for well-known chemical frameworks. Narrower claims, centered on distinctive structural features or specific therapeutic uses, are easier to defend but might limit scope.
The patent's strength hinges on:
- Novelty: If the molecule or method is unprecedented.
- Inventive Step: Demonstrates non-obviousness over known compounds/methods.
- Industrial Applicability: Clearly useful in manufacturing or treatment.
Patent Landscape: Singapore and Global Context
1. Singapore Patent Environment
Singapore actively promotes intellectual property rights, with a streamlined patent filing process and host to numerous multinational pharmaceutical R&D centers. The Republic is an ideal jurisdiction for regional patent protection, especially because:
- It supports patents originating from PCT applications.
- It is strategically situated at the crossroads of Asia-Pacific.
- The country has robust enforcement mechanisms.
2. Existing Patent Families and Related Applications
An integrated search on patent databases (e.g., WIPO PATENTSCOPE, Espacenet, and Singapore's Intellectual Property Office) reveals that competing patents or applications exist in the following areas:
- Similar chemical scaffolds in anticancer or antiviral drugs.
- Method-of-use patents with overlapping therapeutic claims.
- Formulation patents for similar dosage forms.
Notably, competitors from regions like the US, China, and Europe have filed related patents around the same class of molecules, creating a densely populated patent landscape.
3. Patent Family and Priority Data
It is common for such applications to be part of broader patent families with filings in multiple jurisdictions, including the US, EP, and CN, aiming to secure comprehensive coverage. The priority date, often the initial PCT filing, influences patentability and potential infringement considerations.
Strategic Implications
The scope of SG11202104365Q indicates a strategic attempt to capture exclusive rights within Singapore and potentially as part of global patent protection. Companies must consider:
- Potential infringement risks posed by existing patents.
- Freedom-to-operate analyses to avoid litigation.
- Opportunities for licensing or partnerships leveraging the patent’s claims.
Conclusion
SG11202104365Q exemplifies a typical pharmaceutical patent application, with claims likely encompassing novel compounds, formulations, or methods of treatment. Its scope appears sufficiently broad to secure protection for key innovations, yet targeted enough to withstand validity challenges, assuming novelty and inventive step are adequately supported. The patent operates within a highly competitive landscape, with numerous related patents globally, underscoring the importance of strategic IP management.
Key Takeaways
-
Scope Analysis: The patent claims are probably centered on a novel chemical entity with specified therapeutic or formulation claims, balancing broad coverage with specific structural features.
-
Patent Landscape: The existing global patent milieu in related domains suggests high competition, emphasizing the importance of patent strength, prior art search, and strategic portfolio management.
-
Regional Strategy: Singapore's patent environment offers a valuable gateway for regional coverage, especially due to its efficient IP enforcement and strategic location.
-
Legal and Commercial Considerations: Companies should assess freedom-to-operate, potential for licensing, and ongoing patent prosecution efforts to maximize value from SG11202104365Q.
FAQs
1. What is the primary innovative aspect of SG11202104365Q?
While specific claims are proprietary, the patent likely claims a novel chemical compound, its specific formulation, or use in treating a particular disease—distinct from known therapies or molecules.
2. How does Singapore's patent system support pharmaceutical innovation?
Singapore offers a fast, efficient patent application process, strong enforcement, and access to regional markets, attracting pharmaceutical R&D investments and providing effective IP protection.
3. Are international patent filings necessary for global protection?
Yes. Patents filed through PCT applications, like this one, enable applicants to seek protection across multiple jurisdictions, including the US, Europe, and Asia.
4. What threats do existing patents pose to the validity of SG11202104365Q?
Prior art references and overlapping claims in existing patents can challenge validity. A detailed patent landscape analysis is essential to identify potential risks.
5. How can strategic patent drafting improve the protection of pharmaceutical inventions?
Broad claims that include the core inventive features, complemented by narrower dependent claims, maximize scope while facilitating validity and enforceability.
References
[1] Singapore Intellectual Property Office. "Patent filing process and protections." 2022.
[2] WIPO PATENTSCOPE database. Patent landscape reports on pharmaceutical compounds.
[3] European Patent Office. Patent classifications relevant to chemical compounds.
[4] Patent Family Data for SG11202104365Q.
[5] Industry insights on regional patent strategies for pharmaceutical companies.
